​

Fortrea (FTRE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FTRE Stock Forecast

Fortrea (FTRE) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $23.00 and a low of $16.00. This represents a 19.12% increase from the last price of $16.79.

$15 $21 $27 $33 $39 $45 High: $23 Avg: $20 Low: $16 Last Closed Price: $16.79

FTRE Stock Rating

Fortrea stock's rating consensus is Hold, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (41.67%), 6 Hold (50.00%), 1 Sell (8.33%), and 0 Strong Sell (0.00%).

Hold
Total 12 1 6 5 0 Strong Sell Sell Hold Buy Strong Buy

FTRE Price Target Upside V Benchmarks

TypeNameUpside
StockFortrea19.12%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-522
Avg Price Target-$19.80$16.45
Last Closing Price$16.79$16.79$16.79
Upside/Downside-17.93%-2.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26-55-212
Aug, 26-551112
Jul, 26-55-212
Jun, 26-55-212
May, 26-56-112
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 30, 2026Deutsche Bank$20.00$19.930.35%19.12%
Jul 30, 2026Eric ColdwellRobert W. Baird$23.00$20.4012.75%36.99%
Jul 30, 2026Barclays$22.00$20.407.84%31.03%
Jul 13, 2026Mizuho Securities$16.00$17.76-9.91%-4.71%
Jun 24, 2026Luke SergottBarclays$18.00$16.469.36%7.21%
May 07, 2026Justin BowersDeutsche Bank$14.00$16.14-13.26%-16.62%
May 06, 2026Truist Financial$19.00$15.1625.33%13.16%
May 06, 2026Robert W. Baird$20.00$14.5337.65%19.12%
May 06, 2026Barclays$16.00$14.5310.12%-4.71%
Apr 14, 2026Barclays$11.00$9.3817.27%-34.48%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 04, 2026Cowen & Co.BuyBuyhold
Jul 31, 2026CitigroupBuyBuyhold
Jul 30, 2026Deutsche BankHoldHoldhold
Jul 29, 2026Evercore ISIOutperformOutperformhold
May 07, 2026Deutsche BankHoldHoldhold
May 06, 2026Cowen & Co.BuyBuyhold
May 06, 2026CitigroupBuyBuyhold
Jan 22, 2026Cowen & Co.HoldHoldhold
Jan 06, 2026Evercore ISIOutperformOutperformupgrade
Dec 11, 2025CitigroupNeutralBuyupgrade

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.04$-3.67$-10.81---
Avg Forecast$1.44$0.51$1.29$1.72$2.30$2.96
High Forecast$1.47$0.55$1.52$2.09$2.41$3.06
Low Forecast$1.40$0.46$1.10$1.46$2.20$2.92
Surprise %-102.78%-819.61%-937.98%---

Revenue Forecast

$3B $3B $3B $3B $3B $3B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.84B$2.70B$2.72B---
Avg Forecast$3.11B$2.70B$2.73B$2.85B$2.97B$3.19B
High Forecast$3.12B$2.78B$2.78B$2.86B$3.01B$3.27B
Low Forecast$3.08B$2.67B$2.71B$2.84B$2.94B$3.15B
Surprise %-8.68%-0.23%-0.22%---

Net Income Forecast

$-1B $-700M $-400M $-100M $200M $500M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-25.20M$-328.50M$-986.20M---
Avg Forecast$127.73M$45.08M$116.21M$157.70M$204.37M$262.85M
High Forecast$130.84M$49.10M$134.61M$185.86M$213.61M$272.12M
Low Forecast$124.61M$41.06M$97.82M$129.54M$195.13M$258.96M
Surprise %-119.73%-828.71%-948.60%---

FTRE Forecast FAQ

Is Fortrea stock a buy?

Fortrea stock has a consensus rating of Hold, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 6 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Fortrea is a neutral investment for most analysts.

What is Fortrea's price target?

Fortrea's price target, set by 12 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $16 at the low end to $23 at the high end, suggesting a potential 19.12% change from the previous closing price of $16.79.

How does Fortrea stock forecast compare to its benchmarks?

Fortrea's stock forecast shows a 19.12% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Fortrea over the past three months?

  • September 2026: 0% Strong Buy, 41.67% Buy, 41.67% Hold, 0% Sell, 16.67% Strong Sell.
  • August 2026: 0% Strong Buy, 41.67% Buy, 41.67% Hold, 8.33% Sell, 8.33% Strong Sell.
  • July 2026: 0% Strong Buy, 41.67% Buy, 41.67% Hold, 0% Sell, 16.67% Strong Sell.

What is Fortrea’s EPS forecast?

Fortrea's average annual EPS forecast for its fiscal year ending in December 2026 is $1.72, marking a -115.91% decrease from the reported $-10.81 in 2025. Estimates for the following years are $2.3 in 2027, and $2.96 in 2028.

What is Fortrea’s revenue forecast?

Fortrea's average annual revenue forecast for its fiscal year ending in December 2026 is $2.85B, reflecting a 4.75% increase from the reported $2.72B in 2025. The forecast for 2027 is $2.97B, and $3.19B for 2028.

What is Fortrea’s net income forecast?

Fortrea's net income forecast for the fiscal year ending in December 2026 stands at $157.7M, representing a -115.99% decrease from the reported $-986M in 2025. Projections indicate $204.37M in 2027, and $262.85M in 2028.